In 2007, Patrice Cani (FNRS-WELBIO researcher) and his team at the Louvain Drug Research Institute of UCLouvain, in close collaboration with Willem de Vos, professor at UWageningen, discovered the beneficial effects of an intestinal bacteria, Akkermansia muciniphila1, able to moderate the development of obesity and type 2 diabetes, in mice. In 2017, the team discovered (still in the mouse) that the use of a pasteurized form of Akkermansia leads to an even greater protection than the living bacterium regarding various cardiovascular disease risk factors such as insulin resistance, hypercholesterolemia, or the storage of fat in adipose tissue.
Following these discoveries, the UCLouvain team, in collaboration with the Cliniques universitaires Saint-Luc2, developed a clinical study in order to administer the bacteria to humans. For this, it was necessary to develop the capacity to produce the bacterium in large quantity and to make sure that the tests would be without risk for the participants.
The UCLouvain researchers administered Akkermansia to overweight or obese volunteers, all displaying insulin resistance (pre-diabetes type 2) and metabolic syndrome, in other words, having several elevated risk factors for cardiovascular diseases. The volunteers were randomly divided into 3 groups (placebo, live bacteria and pasteurized bacteria) and were asked not to change their dietary habits or their physical activity. Akkermansia was provided as a nutritional supplement.
The primary goal of this UCLouvain study was to demonstrate the feasibility of daily ingesting Akkermansia for 3 months, without risk. Clara Depommier and Amandine Everard, UCLouvain researchers, observed excellent compliance (the supplements were easy to ingest) and tolerance (there were no side effects) in the groups taking live or pasteurized bacteria.
The conclusions are clear: the tests in humans confirm what had already been observed in mice. Ingestion of the (pasteurized) bacterium prevented the deterioration of the health status of the subjects (pre-diabetes, cardiovascular risks). Even better, the researchers observed a decrease in inflammation markers in the liver, a slight decrease in the body weight of the subjects (2.3 kg on average)3 as well as a lowering of cholesterol levels. In contrast, the metabolic parameters (insulin resistance or hypercholesterolemia) in placebo subjects continued to deteriorate over time.
Who does it benefit? According to the WHO, one in three people die every day from cardiovascular disease worldwide. In Western countries, one in two people is overweight and has increased cardiovascular risks. This research of the UCLouvain would limit these risks and therefore potentially have an impact (limit the effects) on half of the population, if properly used.
In conclusion, this pilot study demonstrates the feasibility of administrating (pasteurized) Akkermansia bacteria to humans in the form of a food supplement and reports encouraging results on the effectiveness of the Akkermansia-based dietary supplements to reduce cardio-metabolic risk factors. These results pave the way for a large-scale study, to confirm/elaborate these first results, but also endorse the commercialization of the bacteria as food supplements.
A generic email address has been created for the public who wants more information about Akkermansia bacteria: [email protected].
Learn and see more: A bacteria likely to reduce the cardiovascular risks of 1 in 2 people
The Latest on: Akkermansia
[google_news title=”” keyword=”Akkermansia” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Akkermansia
- Researchers Discover Enzymes Advancing Universal Blood Donor Developmenton May 5, 2024 at 5:00 pm
Collaborative efforts between researchers and Hachem’s lab led to the discovery that enzymes from the gut bacteria Akkermansia muciniphila could break down carbohydrate extensions of both type A and B ...
- Revolutionary discovery! Bacteria converts blood to universal donor typeon May 5, 2024 at 4:43 am
A team of researchers has made a groundbreaking discovery, unearthing a common bacteria capable of modifying enzymes in blood. This modification effectively transforms any blood type into the ...
- Groundbreaking discovery could create 'universal donor blood' for first time everon May 5, 2024 at 12:20 am
The way this breakthrough could be possible is thanks to a bacteria enzyme that's found in almost everyone's guts. It's an enzyme that removes antigens from red blood cells, which is something that ...
- Scientists may have found a way to make a universal donor bloodon May 4, 2024 at 12:10 pm
Scientists have found a type of bacteria enzyme that can strip away blood types and create universal donor blood.
- Scientists Intrigued by Bacteria That Turns Any Blood Into Universal Donor Typeon May 4, 2024 at 5:30 am
A team of researchers claims to have found a way to manipulate the enzymes present in blood supplies, potentially bringing them a step closer to creating a type of blood that could be given to ...
- A gut bacteria could hold the key to universal blood, revolutionizing transfusion medicineon May 1, 2024 at 9:22 pm
Study found that exoglycosidases from Akkermansia muciniphila effectively target blood group antigens, potentially converting A and B blood types to ABO-universal blood.
- Why universal blood donations might become a reality soonon April 30, 2024 at 8:53 am
A study published this week in the journal Nature Microbiology showed that bacteria in the intestines of human beings produces certain enzymes that could convert a person’s blood group to type O. Rese ...
- Bacterial enzyme strips away blood types to create universal donor bloodon April 29, 2024 at 9:44 pm
Using enzymes produced by a bacteria that almost everyone has in their gut, researchers have removed the antigens from red blood cells that determine blood type, putting us within reach of producing ...
- Enzyme discovery paves the way for developing universal donor bloodon April 29, 2024 at 2:03 pm
Researchers at DTU and Lund University have discovered enzymes that remove hindrances that stood in the way of developing universal donor blood.
- Enzymes Discovered in Gut Bacteria Can Change a Donor's Blood Groupson April 29, 2024 at 8:01 am
When a life hangs in the balance, blood transfusions can help sustain a patient – but only if the donor's blood type is a match.
via Bing News
